169 related articles for article (PubMed ID: 12120886)
1. A dose finding study of carboplatin and gemcitabine in advanced non-small cell lung cancer.
Tognoni A; Pensa F; Vaira F; Vigani A; Caness P; Sinaccio G; Pronzato P
J Chemother; 2002 Jun; 14(3):296-300. PubMed ID: 12120886
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study.
Thomas P; Robinet G; Ferri-Dessens RM; Léna H; Gouva S; Vernejoux JM; Kleisbauer JP
Lung Cancer; 2002 May; 36(2):191-8. PubMed ID: 11955654
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study.
Soo RA; Lim HL; Wang LZ; Lee HS; Millward MJ; Tok LT; Lee SC; Lehnert M; Goh BC
Cancer Chemother Pharmacol; 2003 Aug; 52(2):153-8. PubMed ID: 12750842
[TBL] [Abstract][Full Text] [Related]
4. RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer.
Choy H; Jain AK; Moughan J; Curran W; Whipple G; Demas WF; Ettinger DS
J Thorac Oncol; 2009 Jan; 4(1):80-6. PubMed ID: 19096311
[TBL] [Abstract][Full Text] [Related]
5. A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer.
Tomizawa Y; Ishihara S; Iijima H; Imai H; Sato K; Yatomi M; Iwasaki Y; Yamada H; Kobayashi G; Ishida E; Inoue T; Aoki H; Watanabe S; Kawashima O; Mori M; Saito R
Am J Clin Oncol; 2007 Oct; 30(5):498-502. PubMed ID: 17921710
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.
Gajra A; Mehdi SA; Kirshner J; Newman N; Graziano SL
Lung Cancer; 2001 May; 32(2):189-96. PubMed ID: 11325490
[TBL] [Abstract][Full Text] [Related]
7. Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies.
Gray HJ; Bell-McGuinn K; Fleming GF; Cristea M; Xiong H; Sullivan D; Luo Y; McKee MD; Munasinghe W; Martin LP
Gynecol Oncol; 2018 Mar; 148(3):507-514. PubMed ID: 29352572
[TBL] [Abstract][Full Text] [Related]
8. Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer.
Iaffaioli RV; Tortoriello A; Facchini G; Caponigro F; Gentile M; Marzano N; Gravina A; Dimitri P; Costagliola G; Ferraro A; Ferrante G; De Marino V; Illiano A
J Clin Oncol; 1999 Mar; 17(3):921-6. PubMed ID: 10071285
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancer.
Langer CJ; Gandara DR; Calvert P; Edelman MJ; Ozols RF
Semin Oncol; 1999 Feb; 26(1 Suppl 4):12-8. PubMed ID: 10201516
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of gemcitabine and carboplatin in non-small cell lung cancer.
Carmichael J; Allerheiligen S; Walling J
Semin Oncol; 1996 Oct; 23(5 Suppl 10):55-9. PubMed ID: 8893883
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and carboplatin in combination with gemcitabine: a phase I-II trial in patients with advanced non-small-cell lung cancer. Gruppo Studio Tumori Polmonari Veneto (GSTPV).
Favaretto A; Ceresoli GL; Paccagnella A; Barbieri F; Bearz A; Ghiotto C; Oniga F; Schiavon S; Frustaci S; Villa E
Ann Oncol; 2000 Nov; 11(11):1421-6. PubMed ID: 11142482
[TBL] [Abstract][Full Text] [Related]
12. The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.
Davies AM; Ruel C; Lara PN; Lau DH; Gumerlock PH; Bold R; Shibata S; Lenz HJ; Schenkein DP; Gandara DR
J Thorac Oncol; 2008 Jan; 3(1):68-74. PubMed ID: 18166843
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of gemcitabine and carboplatin in patients with advanced non-small cell lung cancer and a performance status of 2.
Kim YH; Kubota K; Goto K; Yoh K; Niho S; Ohmatsu H; Saijo N; Nishiwaki Y
Jpn J Clin Oncol; 2009 Sep; 39(9):576-81. PubMed ID: 19520688
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer.
Sakurai R; Tomizawa Y; Yoshii A; Miura Y; Tsurumaki H; Kaira K; Sunaga N; Kawashima O; Hisada T; Yamada M; Saito R
Cancer Chemother Pharmacol; 2018 Jan; 81(1):103-109. PubMed ID: 29124327
[TBL] [Abstract][Full Text] [Related]
15. A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer.
Surmont V; Aerts JG; van Klaveren RJ; Tournoy K; Tan KY; Vernhout RM; Schmitz PI; Legrand C; Hoogsteden HC; van Meerbeeck JP
Oncology; 2010; 78(3-4):267-70. PubMed ID: 20523087
[TBL] [Abstract][Full Text] [Related]
16. The development of gemcitabine and carboplatin in the treatment of non-small-cell lung cancer.
Cullen M
Lung Cancer; 2005 Oct; 50 Suppl 1():S5-7. PubMed ID: 16291432
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group study.
Ng EW; Sandler AB; Robinson L; Einhorn LH
Am J Clin Oncol; 1999 Dec; 22(6):550-3. PubMed ID: 10597737
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine and carboplatin in combination: phase I and phase II studies.
Langer CJ; Calvert P; Ozols RF
Semin Oncol; 1998 Aug; 25(4 Suppl 9):51-4. PubMed ID: 9728585
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial.
Tassinari D; Drudi G; Panzini I; Pasini G; Arcangeli V; Fochessati F; Gianni L; Mianulli AM; Oliverio G; Pasquini E; Sartori S; Ravaioli A
Int J Clin Oncol; 2001 Dec; 6(6):279-83. PubMed ID: 11828946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
